Atara Biotherapeutics
ATRA
ATRA
53 hedge funds and large institutions have $461M invested in Atara Biotherapeutics in 2015 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 26 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
53
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$91.8M | |
| 2 | +$28.2M | |
| 3 | +$16.9M | |
| 4 |
Jennison Associates
New York
|
+$12.5M |
| 5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$10.5M |
Top Sellers
| 1 | -$27.2M | |
| 2 | -$1.41M | |
| 3 | -$538K | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$355K |
| 5 |
JPMorgan Chase & Co
New York
|
-$254K |